TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $115,000 | +248.5% | 240,209 | +719.8% | 0.00% | +100.0% |
| Q4 2018 | $33,000 | -26.7% | 29,300 | +98.3% | 0.00% | 0.0% |
| Q1 2018 | $45,000 | -78.6% | 14,778 | -55.7% | 0.00% | -66.7% |
| Q4 2017 | $210,000 | +268.4% | 33,378 | +173.0% | 0.00% | +200.0% |
| Q1 2016 | $57,000 | -81.0% | 12,227 | -59.2% | 0.00% | -87.5% |
| Q4 2015 | $300,000 | – | 29,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 317,900 | $11,647,000 | 4.28% |
| Opaleye Management Inc. | 175,000 | $6,412,000 | 2.98% |
| Graticule Asia Macro Advisors LLC | 413,200 | $15,139,000 | 2.02% |
| BB BIOTECH AG | 1,477,114 | $54,121,000 | 1.61% |
| Iguana Healthcare Management, LLC | 75,000 | $2,748,000 | 1.16% |
| Granite Point Capital Management, L.P. | 79,250 | $2,904,000 | 1.06% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 458,202 | $16,788,000 | 0.89% |
| Ghost Tree Capital, LLC | 130,000 | $4,764,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 605,393 | $22,182,000 | 0.84% |
| HealthCor Management, L.P. | 467,200 | $17,118,000 | 0.82% |